DuPont de Nemours, Inc.

DuPont de Nemours, Inc.

118.50
EUR
-0.10
(-0.08%)
0.00EPS
358.61P/E
16.95BMarket Cap
Nov 03Next Earn
DuPont de Nemours, Inc.
FRA:6D8
(Frankfurt Stock Exchange)

Recent

price

118.50

P/E

ratio

358.61

div

yld

2.24%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
USD
429.05
469.86
436.93
433.08
447.09
388.46
391.14
66.49
88.37
62.05
58.48
69.46
78.34
44.1
48.08
49.21
34.18
Revenue per Share
15.75
18.81
6.48
33.74
26.38
58.49
32.31
6.6
15.04
2
-12.04
35.75
35.31
2.82
5.03
-5.6
0.4
Basic EPS, GAAP
32.43
29.26
31.35
59.36
49.98
59.6
-26.45
-5.05
17.98
4.94
16.42
-0.36
7.52
-6.11
3.18
3.63
7.61
Free Cash Flow per Basic Share
8.11
9.85
15.77
11.22
15.53
17.94
20
19.34
13.65
6.48
3.6
3.48
3.92
4.34
4.54
4.29
3.03
Dividend per Share
137.55
138.89
126.23
170.99
143.23
172.23
193.11
387.99
374.01
166.49
157.33
154.94
173.99
169.34
167.59
102.05
101.96
Book Value per Share
-5.07
2.2
-4.29
43.21
15.73
45.15
34.84
29.12
179.05
-23.38
47.93
18.93
28.89
12.17
90.51
22.49
23.25
Tangible Book Value per Share
125
128
130
132
130
126
123
176
256
249
245
181
166
150
140
139
138
Basic Weighted Avg Shares
53,674
59,985
56,786
57,080
58,167
48,778
48,158
11,672
22,594
15,436
14,338
12,566
13,017
6,614
6,719
6,849
4,701
Sales/Revenue/Turnover
5.81
6.71
6.95
7.45
9.48
12.44
11.21
-5.68
9.52
12.72
12.61
14.88
15.53
12.43
11.12
12.56
8.23
Operating Margin (%)
2,962
2,883
2,698
2,681
2,747
2,521
2,862
3,969
5,918
3,195
3,094
1,112
1,135
580
635
647
630
Depreciation Expense
2,310
2,742
1,182
4,787
3,772
7,685
4,318
1,159
3,845
498
-2,951
6,467
5,868
423
703
-779
55
Net Income, GAAP
17.17
22.69
33.93
29.22
27.08
21.62
0.2
- -
32.5
- -
- -
16.41
26.73
- -
182.05
51
100
Effective Tax Rate (%)
4.3
4.57
2.08
8.39
6.48
15.76
8.97
9.93
17.02
3.23
-20.58
51.46
45.08
6.4
10.46
-11.37
1.17
Profit Margin (%)
10,234
9,788
12,191
13,006
12,674
12,826
11,055
23,765
53,343
1,653
16,782
9,372
7,537
4,416
15,279
3,270
2,855
Working Capital
20,605
18,310
19,919
16,820
18,741
16,215
20,456
30,056
12,624
13,617
15,611
10,632
7,774
7,800
5,323
3,134
3,125
LT Debt
22,642
23,291
21,867
27,924
23,354
26,183
27,229
101,927
95,900
41,556
39,070
27,050
27,017
24,725
23,793
14,103
13,881
Total Equity
5.67
6.07
3.51
10.72
8.84
18.62
10.01
- -
0.05
- -
- -
3.44
3.5
- -
-1.37
0.8
- -
Return on Invested Capital (%)
7.82
8.18
4.79
12.48
9.95
19.27
11.06
- -
3.05
- -
- -
14.83
16.95
- -
1.16
-2.76
0.11
Return on Capital (%)
11.46
13.3
4.79
22.36
16.61
36.91
16.8
1.84
3.95
0.74
-7.42
19.92
22.14
1.66
2.95
-4.18
0.3
Return on Common Equity (%)

Capital Structure

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
60
40
- -
LT Borrowings
3,125
3,132
3,125
LT Finance Leases
9
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
136
137
135
Market Capitalization
- -
- -
19,365

Working Capital

USD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
5,575
5,643
4,856
Cash, Cash Equivalents & STI
715
710
1,740
Accounts Receivable, Net
910
1,699
1,751
Inventories
1,172
1,209
1,210
Total Current Liabilities
2,305
2,103
2,001
Payables & Accruals
1,931
1,764
2,001
ST Debt
60
40
- -
Deferred Revenue
- -
- -
- -

Growth Rates

USD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
12.59%
-16.77%
-40.73%
Free Cash Flow
-311.25%
-486.32%
13.48%
Net Income, GAAP
-123.07%
-113.16%
-210.81%
Sales/Revenue/Turnover
-7.67%
-10.89%
1.93%
Total Cash Common Dividend
-5.9%
-6.73%
-5.98%

Quarterly Revenue

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
2,931
3,171
2,862
3,092
6,719
2025
1,612
1,749
3,072
-1,871
6,849
2026
1,681
1,819
- -
- -
- -

Quarterly Earnings Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.34
1.28
3.27
-0.85
5.03
2025
-4.22
0.42
-0.88
-0.91
-5.6
2026
1.18
1.05
- -
- -
- -

Quarterly Dividends Per Share

USD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1.13
1.13
1.14
1.14
4.54
2025
1.23
1.22
1.23
0.59
4.29
2026
0.6
0.6
- -
- -
- -
Business
DuPont de Nemours, Inc. (NYSE: DD) develops and manufactures high-performance engineered products and technology-based materials serving healthcare, water treatment, electronics, transportation, construction, safety and protection, and industrial applications worldwide. Headquartered in Wilmington, Delaware, and founded in 1802, the company operates through two primary segments: ElectronicsCo, which provides semiconductor fabrication consumables such as chemical mechanical planarization slurries, microlithography materials, electronic polymers, and specialty films for displays including organic light emitting diodes; and IndustrialsCo, which offers water purification solutions including reverse osmosis membranes and ion exchange resins, medical packaging and devices, high-performance fibers such as Kevlar and Nomex, automotive and aerospace materials for electric vehicles and engine efficiency, building products for energy efficiency and fire resilience, and flexographic printing and digital inks. The company maintains manufacturing facilities in the United States including Virginia, West Virginia, Alabama, and Texas, as well as internationally in Belgium and China, targeting semiconductor manufacturers, medical device producers, water treatment facilities, automotive and aerospace suppliers, construction firms, and industrial equipment providers. Recent developments include the August 2025 agreement to divest its Aramids business encompassing Kevlar and Nomex brands to Arclin for approximately $1.8 billion, with the transaction expected to close in early 2026 to sharpen portfolio focus and enhance growth margins while retaining an equity interest; plans to spin off its ElectronicsCo business by the end of 2025 as Qnity; the July 2024 acquisition of medical device contract manufacturer Donatelle Plastics for $313 million to bolster capabilities in injection molding, liquid silicone rubber processing, and device assembly within its healthcare offerings; and a strategic cooperation agreement with Zhen Ding Technology Group announced in October 2024 to advance high-end printed circuit board applications.

Company News

  • DuPont Launches AmberChrom™ SIL Silica Gel for Chromatography to Advance Manufacturing of GLP-1 and Other Peptide Therapeutics

  • A 30.9% Yield Looks Incredible. The Dividend Math Tells Another Story

  • DD Gains on Innovation, Productivity and Strategic Acquisitions

  • DuPont de Nemours, Inc. $DD Stock: Krilogy Financial LLC Increases Position

  • DuPont Announces Regular Quarterly Dividend on Common Stock

  • GAMMA Investing LLC Grows Stock Position in DuPont de Nemours, Inc. $DD

  • Moody National Bank Trust Division Makes New Investment in DuPont de Nemours, Inc. $DD

  • DuPont de Nemours (NYSE:DD) & Marubeni (OTCMKTS:MARUY) Critical Analysis

  • DuPont Schedules Third Quarter 2026 Earnings Conference Call

  • DuPont Announces Winners of Third Annual Tyvek® Sustainable Healthcare Packaging Awards

  • Mitsubishi (OTCMKTS:MSBHF) and DuPont de Nemours (NYSE:DD) Financial Survey

  • DuPont Expands Sugar Separation Expertise With New Digital Tool

  • DuPont Launches Sugar Separation Advisor to Accelerate Sugar and Sweetener Purification

  • DuPont: Secular Growth And Margin Expansion Should Drive Good Upside

  • Caliway Announces Positive Phase 2 Results of CBL-514 in Dercum's Disease, Achieving Primary Endpoint with Statistically Significant and Sustained Pain Reduction

  • Squarepoint Ops LLC Lowers Holdings in DuPont de Nemours, Inc. $DD

  • Integrated Wealth Concepts LLC Sells 13,713 Shares of DuPont de Nemours, Inc. $DD

  • Here's Why You Should Hold DuPont Stock in Your Portfolio for Now

  • DuPont de Nemours, Inc. $DD Shares Sold by Corient Private Wealth LP

  • DuPont Expands Tyvek Portfolio With Lower-Carbon Material Innovation